Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 2Completed 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 9Other hematologic neoplasm 8Plasma cell 6Gastrointestinal 6Myeloid 5CNS 5Genitourinary 4Breast 4Dermatologic 3Thoracic 2Sarcoma 2Endocrine 2Other solid neoplasm 1NET 1Classical hematology 1

Conditions

Oligodendroglioma 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Gliosarcoma 1Glioma 1Glioblastoma 1Dendritic Cell Sarcoma, Interdigitating 1Astrocytoma 1

Interventions

Cyclophosphamide 26Temozolomide 23Doxorubicin 22Radiotherapy 21Filgrastim 19Ifosfamide 15pazopanib 14Gemcitabine 14Etoposide 13Bevacizumab 13Irinotecan 12Cisplatin 12Magnetic Resonance Spectroscopy 11Imatinib Mesylate 11Granulocyte Colony-Stimulating Factor 11Carboplatin 11Radiation 9Methotrexate 9pembrolizumab 8fludarabine phosphate 8Rituximab 8Paclitaxel 8Docetaxel 8Cyclosporine 8Busulfan 8Antilymphocyte Serum 8fludarabine 7Vincristine 7Radiotherapy, Intensity-Modulated 7Mycophenolic Acid 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Panobinostat × Sarcoma × Clear all
NCT01282476 2017-05-09

Panobinostat With Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma

Massachusetts General Hospital

Phase 2 Terminated
18 enrolled 20 charts
LymphoidSarcoma

Lymphoma, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

NCT00848523 2010-07-16

Study of LBH589 (Panobinostat) to Treat Malignant Brain Tumors

Neurological Surgery, P.C.

Phase 2 Terminated
6 enrolled
CNSSarcoma

Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡